Home/Cipla/Mr. Kedar Upadhye
MK

Mr. Kedar Upadhye

Global Chief Financial Officer

Cipla

Cipla Pipeline

DrugIndicationPhase
Respiratory Inhalation Portfolio (Generic)Asthma, COPDANDA Filed/Approved
Bevacizumab BiosimilarVarious Cancers (Colorectal, Lung, etc.)Phase III / Registration
Pembrolizumab BiosimilarVarious CancersEarly Development
Complex Generic Oncology InjectablesBreast Cancer, Pancreatic CancerANDA Filed/Approved